Citations (139)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Gregory W. Mattingly, Oscar Necking, Simon Nitschky Schmidt, Elin Reines & Hongye Ren. (2023) Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies. Current Medical Research and Opinion 39:4, pages 613-619.
Read now
Read now
Seetal Dodd, Michael Bauer, Andre F. Carvalho, Harris Eyre, Maurizio Fava, Siegfried Kasper, Sidney H. Kennedy, Jon-Paul Khoo, Carlos Lopez Jaramillo, Gin S. Malhi, Roger S. McIntyre, Philip B. Mitchell, Angela Marianne Paredes Castro, Aswin Ratheesh, Emanuel Severus, Trisha Suppes, Madhukar H. Trivedi, Michael E. Thase, Lakshmi N. Yatham, Allan H. Young & Michael Berk. (2021) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?. The World Journal of Biological Psychiatry 22:7, pages 483-494.
Read now
Read now
Gang Wang, Changsu Han, Chia-Yih Liu, Sandra Chan, Tadafumi Kato, Wilson Tan, Lili Zhang, Yu Feng & Chee H Ng. (2020) Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatric Disease and Treatment 16, pages 2943-2959.
Read now
Read now
Changsu Han, Gang Wang, Sandra Chan, Tadafumi Kato, Chee H Ng, Wilson Tan, Lili Zhang, Yu Feng & Chia-Yih Liu. (2020) Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatric Disease and Treatment 16, pages 2929-2941.
Read now
Read now
Hong-Qi Li, Song Chi, Qiang Dong & Jin-Tai Yu. (2019) Pharmacotherapeutic strategies for managing comorbid depression and diabetes. Expert Opinion on Pharmacotherapy 20:13, pages 1589-1599.
Read now
Read now
Siegfried Kasper. (2019) Choosing among second-generation antidepressant treatments for depressed patients with cardiac diseases. International Journal of Psychiatry in Clinical Practice 23:2, pages 134-148.
Read now
Read now
Bernardo Dell’Osso, Lucio Oldani, Benedetta Grancini, Alessandro Dario & A Carlo Altamura. (2018) Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases. Neuropsychiatric Disease and Treatment 14, pages 915-918.
Read now
Read now
Seetal Dodd, Philip B. Mitchell, Michael Bauer, Lakshmi Yatham, Allan H. Young, Sidney H. Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Roger S. McIntyre, Michael E. Thase, Raymond W. Lam, Emanuel Severus, Siegfried Kasper & Michael Berk. (2018) Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry 19:5, pages 330-348.
Read now
Read now
Michael Bauer, Emanuel Severus, Hans-Jürgen Möller & Allan H. Young. (2017) Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. International Journal of Psychiatry in Clinical Practice 21:3, pages 166-176.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Victor Hesselbrock, Siegfried Kasper, Jochen Mutschler & Hans-Jürgen Möller. (2017) Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. The World Journal of Biological Psychiatry 18:2, pages 86-119.
Read now
Read now
Markus Dold & Siegfried Kasper. (2017) Evidence-based pharmacotherapy of treatment-resistant unipolar depression. International Journal of Psychiatry in Clinical Practice 21:1, pages 13-23.
Read now
Read now
Arianna Goracci, Rocco N Forgione, Riccardo De Giorgi, Anna Coluccia, Alessandro Cuomo & Andrea Fagiolini. (2016) Practical guidance for prescribing trazodone extended-release in major depression. Expert Opinion on Pharmacotherapy 17:3, pages 433-441.
Read now
Read now
Articles from other publishers (127)
Pontus Strandberg, Axel Nordenskjöld, Robert Bodén, Carl Johan Ekman, Johan Lundberg & Katarzyna Popiolek. (2023) Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode. The Journal of ECT.
Crossref
Crossref
Anders Jorgensen, Emma Neble Larsen, Mathilde Marie Brünnich Sloth, Lars Vedel Kessing & Merete Osler. (2023)
Prescription patterns in unipolar depression: A nationwide Danish
register‐based
study of 113,175 individuals followed for 10 years
. Acta Psychiatrica Scandinavica.
Crossref
Crossref
Susu Lin, Ziwei Chen, Zhaoruncheng Wu, Fei Fei, Zijin Xu, Yingpeng Tong, Wenyu Sun & Ping Wang. (2023) Involvement of PI3K/AKT Pathway in the Rapid Antidepressant Effects of Crocetin in Mice with Depression-Like Phenotypes. Neurochemical Research.
Crossref
Crossref
Jaqueline Kalleian Eserian, Vinícius Paccola Blanco, Lucildes Pita Mercuri, Jivaldo do Rosario Matos & José Carlos Fernandes Galduróz. (2023) Current strategies for tapering psychiatric drugs: Differing recommendations, impractical doses, and other barriers. Psychiatry Research 329, pages 115537.
Crossref
Crossref
Wolfgang Marx, Brenda W. J. H. Penninx, Marco Solmi, Toshi A. Furukawa, Joseph Firth, Andre F. Carvalho & Michael Berk. (2023) Major depressive disorder. Nature Reviews Disease Primers 9:1.
Crossref
Crossref
Carina Meißner, Claire Warren, Tahmine Fadai, Amke Müller, Antonia Zapf, Susanne Lezius, Ann-Kathrin Ozga, Irina Falkenberg, Tilo Kircher & Yvonne Nestoriuc. (2023) Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial. BMC Psychiatry 23:1.
Crossref
Crossref
Juan C. Pascual, Laia Arias & Joaquim Soler. (2023) Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS Drugs 37:6, pages 489-497.
Crossref
Crossref
Scott B. Patten. (2023) Problematic features of episode-based definitions of depression and a preliminary proposal for their replacement. Frontiers in Psychiatry 14.
Crossref
Crossref
Fraser Scott, Elliot Hampsey, Sam Gnanapragasam, Ben Carter, Lindsey Marwood, Rachael W Taylor, Cansu Emre, Lora Korotkova, Jonatan Martín-Dombrowski, Anthony J Cleare, Allan H Young & Rebecca Strawbridge. (2022) Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. Journal of Psychopharmacology 37:3, pages 268-278.
Crossref
Crossref
Michael Bauer. 2023. Praxishandbuch Depression. Praxishandbuch Depression
177
188
.
Irina L. Nikitina, Gulnara G. Gaisina & Aleksandr V. Samorodov. (2022) The mechanism of antidepressant action of a new 3-substituted thiethane-1,1-dioxide derivative in tests of neuropharmacological interaction. Research Results in Pharmacology 8:4, pages 175-183.
Crossref
Crossref
Yifan Shen, Se Wang, Ying Lu & Ce Hao. (2022) Investigations on photochemical behavior of antidepressant sertraline in water by DFT/TDDFT. Journal of Environmental Chemical Engineering 10:6, pages 108657.
Crossref
Crossref
Anders Sørensen, Karsten Juhl Jørgensen & Klaus Munkholm. (2022) Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review. Journal of Affective Disorders 316, pages 177-186.
Crossref
Crossref
María I. Molina-Echeverry, Roger A. Figueroa-Paz, María M. Cardozo-Rengifo, Valentina Galindo-Velasco & Hernán G. Rincón-Hoyos. (2022) La investigación sobre el tratamiento de depresión con base en registros de historia clínica: análisis de una experiencia en un hospital universitario. Revista Colombiana de Psiquiatría.
Crossref
Crossref
Max Heise, Jessica Werthmann, Fionnuala Murphy, Brunna Tuschen-Caffier & Fritz Renner. (2022) Imagine How Good That Feels: The Impact of Anticipated Positive Emotions on Motivation for Reward Activities. Cognitive Therapy and Research 46:4, pages 704-720.
Crossref
Crossref
Hao Yang, Shuzhan Gao, Jiawei Li, Haoran Yu, Jingren Xu, Chenchen Lin, Hua Yang, Changjun Teng, Hui Ma & Ning Zhang. (2022) Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression. Frontiers in Psychiatry 13.
Crossref
Crossref
Shao-Wei Xue, Changxiao Kuai, Yang Xiao, Lei Zhao & Zhihui Lan. (2022) Abnormal Dynamic Functional Connectivity of the Left Rostral Hippocampus in Predicting Antidepressant Efficacy in Major Depressive Disorder. Psychiatry Investigation 19:7, pages 562-569.
Crossref
Crossref
Christophe Moderie, Nicolas Nuñez, Allan Fielding, Stefano Comai & Gabriella Gobbi. (2022) Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression. International Journal of Neuropsychopharmacology 25:6, pages 479-488.
Crossref
Crossref
Yiwen H. Li, Monica N. Williams, Mark J. Jedrzejczak, Lauren A. V. Orenstein & Vinita Singh. (2022) A practical, comprehensive guide to pain management hidradenitis suppurativa. Dermatological Reviews 3:3, pages 137-149.
Crossref
Crossref
Julia J. Meerman, Sophie E. ter Hark, Joost G.E. Janzing & Marieke J.H. Coenen. (2022) The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review. Journal of Affective Disorders 304, pages 1-11.
Crossref
Crossref
Kyoung-Woon Joung, Dong Ho Park, Chang Young Jeong & Hong-Seuk Yang. (2022) Anesthetic care for electroconvulsive therapy. Anesthesia and Pain Medicine 17:2, pages 145-156.
Crossref
Crossref
Franciele Cordeiro Gabriel, Airton Tetelbom Stein, Daniela Oliveira de Melo, Géssica Caroline Henrique Fontes-Mota, Itamires Benício dos Santos, Aliandra Fantinell de Oliveira, Renério Fráguas & Eliane Ribeiro. (2022) Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review. BMJ Open 12:4, pages e051918.
Crossref
Crossref
Christophe Moderie, Nicolas Nuñez, Stefano Comai, Marie Saint-Laurent, Allan Fielding, Nancy Low & Gabriella Gobbi. (2022) Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression. Journal of Clinical Psychopharmacology 42:2, pages 118-124.
Crossref
Crossref
Luca Sforzini, Courtney Worrell, Melisa Kose, Ian M. Anderson, Bruno Aouizerate, Volker Arolt, Michael Bauer, Bernhard T. Baune, Pierre Blier, Anthony J. Cleare, Philip J. Cowen, Timothy G. Dinan, Andrea Fagiolini, I. Nicol Ferrier, Ulrich Hegerl, Andrew D. Krystal, Marion Leboyer, R. Hamish McAllister-Williams, Roger S. McIntyre, Andreas Meyer-Lindenberg, Andrew H. Miller, Charles B. Nemeroff, Claus Normann, David Nutt, Stefano Pallanti, Luca Pani, Brenda W. J. H. Penninx, Alan F. Schatzberg, Richard C. Shelton, Lakshmi N. Yatham, Allan H. Young, Roland Zahn, Georgios Aislaitner, Florence Butlen-Ducuing, Christine Fletcher, Marion Haberkamp, Thomas Laughren, Fanni-Laura Mäntylä, Koen Schruers, Andrew Thomson, Gara Arteaga-Henríquez, Francesco Benedetti, Lucinda Cash-Gibson, Woo Ri Chae, Heidi De Smedt, Stefan M. Gold, Witte J. G. Hoogendijk, Valeria Jordán Mondragón, Eduard Maron, Jadwiga Martynowicz, Elisa Melloni, Christian Otte, Gabriela Perez-Fuentes, Sara Poletti, Mark E. Schmidt, Edwin van de Ketterij, Katherine Woo, Yanina Flossbach, J. Antoni Ramos-Quiroga, Adam J. Savitz & Carmine M. Pariante. (2021) A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry 27:3, pages 1286-1299.
Crossref
Crossref
Young Sup Woo, Won-Myong Bahk, Jeong Seok Seo, Young-Min Park, Won Kim, Jong-Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Seung-Ho Jang, Chan-Mo Yang, Sheng-Min Wang, Myung Hun Jung, Hyung Mo Sung, Il Han Choo, Bo-Hyun Yoon, Sang-Yeol Lee, Duk-In Jon & Kyung Joon Min. (2022) The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 20:1, pages 37-50.
Crossref
Crossref
Yusuke Okada & Manabu Akazawa. (2021) Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis. Social Psychiatry and Psychiatric Epidemiology 57:2, pages 411-422.
Crossref
Crossref
Danielle Hen-Shoval, Aron Weller, Abraham Weizman & Gal Shoval. (2022) Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review. International Journal of Environmental Research and Public Health 19:1, pages 523.
Crossref
Crossref
Anders Sørensen, Karsten Juhl Jørgensen & Klaus Munkholm. (2022) Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review. Therapeutic Advances in Psychopharmacology 12, pages 204512532110676.
Crossref
Crossref
Yanxiang Ye, Chengyu Wang, Xiaofeng Lan, Weicheng Li, Ling Fu, Fan Zhang, Haiyan Liu, Kai Wu, Yanling Zhou & Yuping Ning. (2022) Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder. NeuroImage: Clinical 36, pages 103230.
Crossref
Crossref
Huifeng Zhang, Zhiguo Wu, Lan Cao, Yousong Su, Fan Wang, Wu Hong, Yiyun Cai, Daihui Peng & Yiru Fang. (2022) Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorder. Journal of Affective Disorders 297, pages 68-75.
Crossref
Crossref
Pichit Buspavanich & Roland Ricken. 2022. Therapieresistenz bei Depressionen und bipolaren Störungen. Therapieresistenz bei Depressionen und bipolaren Störungen
135
162
.
M. Bauer, S. Priebe & E. Severus. 2022. Trauma Sequelae. Trauma Sequelae
347
359
.
Lasse Brandt, Andreas Heinz & Jonathan Henssler. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1173
1191
.
Gerd Laux. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1101
1108
.
Jelena Vrublevska & Lubova Renemane. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
823
853
.
Vivien L. Hajak, Göran Hajak, Christoph Ziegelmayer, Simone Grimm & Wolfgang Trapp. (2021) Risk Assessment of Electroconvulsive Therapy in Clinical Routine: A 3-Year Analysis of Life-Threatening Events in More Than 3,000 Treatment Sessions. Frontiers in Psychology 12.
Crossref
Crossref
Gang Wang, Tianmei Si, Joseph S. Imperato, LiLi Yang, Kelly H. Zou, Ying Olive Jin, Elizabeth A. Pappadopulos, Lei Yan, Jim Z. Li & Wei Yu. (2021) Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive‐compulsive disorder: A real‐world evidence analysis from the United States. International Journal of Clinical Practice 75:10.
Crossref
Crossref
Hong Cai, Yu Jin, Shou Liu, Qinge Zhang, Ling Zhang, Teris Cheung, Lloyd Balbuena & Yu-Tao Xiang. (2021) Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies. Journal of Affective Disorders 293, pages 148-158.
Crossref
Crossref
A.G. Sartim, J. Marques, K.M. Silveira, P.H. Gobira, F.S. Guimarães, G. Wegener & S.R. Joca. (2021) Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology 195, pages 108679.
Crossref
Crossref
Youyong Kong, Shuwen Gao, Yingying Yue, Zhenhua Hou, Huazhong Shu, Chunming Xie, Zhijun Zhang & Yonggui Yuan. (2021) Spatio‐temporal graph convolutional network for diagnosis and treatment response prediction of major depressive disorder from functional connectivity. Human Brain Mapping 42:12, pages 3922-3933.
Crossref
Crossref
Hongqi Xiao, Minlan Yuan, Hailong Li, Shiyi Li, Yang Du, Mei Wang, Hongru Zhu, Wei Zhang, Changjian Qiu & Xiaoqi Huang. (2021) Functional connectivity of the hippocampus in predicting early antidepressant efficacy in patients with major depressive disorder. Journal of Affective Disorders 291, pages 315-321.
Crossref
Crossref
Marie Asp, Livia Ambrus, Margareta Reis, Sofie Manninen, Johan Fernström, Daniel Lindqvist & Åsa Westrin. (2021) Differences in antipsychotic treatment between depressive patients with and without a suicide attempt. Comprehensive Psychiatry 109, pages 152264.
Crossref
Crossref
Pingliang Yang, Mengchang Yang, Peng Li, Dejun Cao, Daoyin Gong, Jiahua Lv, Linmei Pu, Sizhou Huang & Yundan Liang. (2021) A Meta-Analysis of 5-Hydroxytryptamine Receptor 1B Polymorphisms With Risk of Major Depressive Disorder and Suicidal Behavior. Frontiers in Psychiatry 12.
Crossref
Crossref
Alena Shalimova, Viktoria Babasieva, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth & Jessica Mwinyi. (2021) Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. Pharmacogenomics 22:8.
Crossref
Crossref
Le Xiao, Xuequan Zhu, Amy Gillespie, Yuan Feng, Jingjing Zhou, Xu Chen, Yuanyuan Gao, Xueyi Wang, Xiancang Ma, Chengge Gao, Yunshi Xie, Xiaoping Pan, Yan Bai, Xiufeng Xu, Gang Wang & Runsen Chen. (2020)
Effectiveness of mirtazapine as add-on to paroxetine
v.
paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial
. Psychological Medicine 51:7, pages 1166-1174.
Crossref
Crossref
Yvonne Nestoriuc, Yiqi Pan, Timm Kinitz, Ella Weik & Meike C. Shedden-Mora. (2021) Informing About the Nocebo Effect Affects Patients’ Need for Information About Antidepressants—An Experimental Online Study. Frontiers in Psychiatry 12.
Crossref
Crossref
Isabelle Jalenques, Chloé Rachez, Urbain Tauveron Jalenques, Silvia Alina Nechifor, Lucile Morel, Florent Blanchard, Bruno Pereira, Sophie Lauron & Fabien Rondepierre. (2021) Cross-cultural evaluation of the French version of the Delusion Assessment Scale (DAS) and Psychotic Depression Assessment Scale (PDAS). PLOS ONE 16:4, pages e0250492.
Crossref
Crossref
Marco Solmi, Alessandro Miola, Giovanni Croatto, Giorgio Pigato, Angela Favaro, Michele Fornaro, Michael Berk, Lee Smith, Joao Quevedo, Michael Maes, Christoph U. Correll & André F. Carvalho. (2021) How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations. Brazilian Journal of Psychiatry 43:2, pages 189-202.
Crossref
Crossref
Diego Chambergo-Michilot, Ana Brañez-Condorena, Ian Falvy-Bockos, Josmel Pacheco-Mendoza & Vicente A. Benites-Zapata. (2021) Efficacy of omega-3 supplementation on sertraline continuous therapy to reduce depression or anxiety symptoms: A systematic review and meta-analysis. Psychiatry Research 296, pages 113652.
Crossref
Crossref
Margit Jehna, Walter Wurm, Daniela Pinter, Katrin Vogel, Anna Holl, Peter Hofmann, Christoph Ebner, Stefan Ropele, Gottfried Fuchs, Hans-Peter Kapfhammer, Hannes Deutschmann & Christian Enzinger. (2021) Do increases in deep grey matter volumes after electroconvulsive therapy persist in patients with major depression? A longitudinal MRI-study. Journal of Affective Disorders 281, pages 908-917.
Crossref
Crossref
Alexander Kautzky, Hans‐Juergen Möller, Markus Dold, Lucie Bartova, Florian Seemüller, Gerd Laux, Michael Riedel, Wolfgang Gaebel & Siegfried Kasper. (2020) Combining machine learning algorithms for prediction of antidepressant treatment response. Acta Psychiatrica Scandinavica 143:1, pages 36-49.
Crossref
Crossref
Lasse Brandt, Andreas Heinz & Jonathan Henssler. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
19
.
Gerd Laux. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
8
.
Rachael W Taylor, Lindsey Marwood, Emanuella Oprea, Valeria DeAngel, Sarah Mather, Beatrice Valentini, Roland Zahn, Allan H Young & Anthony J Cleare. (2020) Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines. International Journal of Neuropsychopharmacology 23:9, pages 587-625.
Crossref
Crossref
Sze Yuen Lew, Siew Huah Lim, Lee Wei Lim & Kah Hui Wong. (2020) Neuroprotective effects of Hericium erinaceus (Bull.: Fr.) Pers. against high-dose corticosterone-induced oxidative stress in PC-12 cells. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Jeremy Y. Ng, Zainib Nazir & Hayley Nault. (2020) Complementary and alternative medicine recommendations for depression: a systematic review and assessment of clinical practice guidelines. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Pichit Buspavanich, Cornelia König & Mazda Adli. (2020) Rezidivprophylaxe der Depression: Pharmakologie. PSYCH up2date 14:06, pages 487-498.
Crossref
Crossref
Michele Protti, Roberto Mandrioli & Laura Mercolini. (2020) Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls. Journal of Pharmaceutical and Biomedical Analysis 191, pages 113597.
Crossref
Crossref
Yena LeeElisa BrietzkeBing CaoYan ChenOuti LinnarantaRodrigo B MansurPaulina CortesMarkus KöstersAmna MajeedJocelyn K TamuraLeanna M W LuiMaj VinbergJaakko KeinänenSteve KiselySadiq NaveedCorrado BarbuiGary ParkerMayowa OwolabiDaisuke NishiJungGoo LeeManit SrisurapanontHartej GillLan GuoVicent Balanzá-MartínezTimo PartonenWillem A NolenJae-Hon LeeJi Hwan KimNiels H ChavannesTatjana EwaisBeatriz Atienza-CarbonellAnna V SilvenNaonori YasumaArtyom GilAndrey NovikovCameron LaceyAnke VersluisSofia von MalortieLai Fong ChanAhmed WaqasMarianna PurgatoJiska Joëlle AardoomJosefina T Ly-UsonKang SimMaria TuineagRianne M J J van der KleijSanne van LuenenSirijit SuttajitTomas HajekYu Wei LeeRichard J PorterMohammad AlsuwaidanJoshua D RosenblatArun V RavindranRaymond W LamRoger S McIntyre. (2020) Development and implementation of guidelines for the management of depression: a systematic review. Bulletin of the World Health Organization 98:10, pages 683-697H.
Crossref
Crossref
Aiste Lengvenyte, Robertas Strumila, Philippe Courtet, Scott Y. H. Kim & Emilie Olié. (2020) “Nothing Hurts Less Than Being Dead”: Psychological Pain in Case Descriptions of Psychiatric Euthanasia and Assisted Suicide from the Netherlands: « Rien ne fait moins mal qu’être mort »: La douleur psychologique dans les descriptions de cas d’euthanasie et de suicide assisté psychiatrique aux Pays-Bas. The Canadian Journal of Psychiatry 65:9, pages 612-620.
Crossref
Crossref
Michele Protti, Roberto Mandrioli, Camilla Marasca, Andrea Cavalli, Alessandro Serretti & Laura Mercolini. (2020) New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews 40:5, pages 1794-1832.
Crossref
Crossref
Terri L Fletcher, Ashley Helm, Viralkumar Vaghani, Mark E Kunik, Melinda A Stanley & Hardeep Singh. (2020) Identifying psychiatric diagnostic errors with the Safer Dx Instrument. International Journal for Quality in Health Care 32:6, pages 405-411.
Crossref
Crossref
Mohamed Z. Habib, Mai A. Ebeid, Yasser el Faramawy, Sherin S.T. Saad, Hekmat M. El Magdoub, Azza A. Attia, Sawsan Aboul-Fotouh & Ahmed M. Abdel-Tawab. (2020) Effects of lithium on cytokine neuro-inflammatory mediators, Wnt/β-catenin signaling and microglial activation in the hippocampus of chronic mild stress-exposed rats. Toxicology and Applied Pharmacology 399, pages 115073.
Crossref
Crossref
A. John RushMichael E. Thase. (2020) Improving Depression Outcome by Patient-Centered Medical Management. FOCUS 18:2, pages 244-254.
Crossref
Crossref
Hitoshi Sakurai, Hiroyuki Uchida, Masaki Kato, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Toshiaki Kikuchi, Asuka Katsuki, Ikuko Kishida, Yuka Sugawara Kikuchi & Norio Yasui-Furukori. (2020) Pharmacological management of depression: Japanese expert consensus. Journal of Affective Disorders 266, pages 626-632.
Crossref
Crossref
Gregor Gryglewski, René Seiger, Pia Baldinger-Melich, Jakob Unterholzner, Benjamin Spurny, Thomas Vanicek, Andreas Hahn, Siegfried Kasper, Richard Frey & Rupert Lanzenberger. (2020) Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression. International Journal of Neuropsychopharmacology 23:1, pages 20-25.
Crossref
Crossref
Ryan Rodriguez & Daniel R. Touchette. (2020) Part II: Statistics in practice: Statistics overview. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 3:2, pages 554-559.
Crossref
Crossref
Chung-Yi Lin, I-Ming Chen, Hui-Ju Tsai, Chi-Shin Wu & Shih-Cheng Liao. (2020) Effectiveness of electroconvulsive therapy on treatment-resistant depressive disorder: A population-based mirror-image study. Journal of Psychiatric Research 121, pages 101-107.
Crossref
Crossref
Sofia H. Kanders, Claudia Pisanu, Marcus Bandstein, Jörgen Jonsson, Enrique Castelao, Giorgio Pistis, Mehdi Gholam‐Rezaee, Chin B. Eap, Martin Preisig, Helgi B. Schiöth & Jessica Mwinyi. (2019) A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants. Drug Development Research 81:1, pages 102-113.
Crossref
Crossref
I.S. Losenkov, E.V. Plotnikov, E.V. Epimakhova & N.A. Bokhan. (2020) Lithium in the psychopharmacology of affective disorders and mechanisms of its effects on cellular physiology. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:11, pages 108.
Crossref
Crossref
Michael P. Hengartner. (2020) How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Therapeutic Advances in Psychopharmacology 10, pages 204512532092169.
Crossref
Crossref
Jelena Vrublevska & Lubova Renemane. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
31
.
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J. M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova & Bob Wilffert. (2019) Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression. Frontiers in Pharmacology 10.
Crossref
Crossref
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Lyudmila A. Levchuk, Diana Z. Osmanova, Ekaterina V. Mikhalitskaya, Anton J.M. Loonen, Fokko J. Bosker, German G. Simutkin, Nikolay A. Bokhan, Bob Wilffert & Svetlana A. Ivanova. (2019) Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients. Journal of Affective Disorders 259, pages 432-439.
Crossref
Crossref
T. Vanicek, G. S. Kranz, B. Vyssoki, A. Komorowski, G. Fugger, A. Höflich, Z. Micskei, S. Milovic, R. Lanzenberger, A. Eckert, S. Kasper & R. Frey. (2019)
Repetitive enhancement of serum
BDNF
subsequent to continuation
ECT
. Acta Psychiatrica Scandinavica 140:5, pages 426-434.
Crossref
Crossref
Jasmina Mallet, Philip Gorwood, Yann Le Strat & Caroline Dubertret. (2019) Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review. International Journal of Neuropsychopharmacology 22:10, pages 651-664.
Crossref
Crossref
Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael Liebowitz, Arun Ravindran, Raphael Gaillard, Hans Van Den Ameele, Sheldon Preskorn, Husseini Manji, David Hough, Wayne C Drevets & Jaskaran B Singh. (2019) Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). International Journal of Neuropsychopharmacology 22:10, pages 616-630.
Crossref
Crossref
Sagar V. Parikh, Jolene R. Bostwick & Danielle S. Taubman. (2019) Videoconferencing Technology to Facilitate a Pilot Training Course in Advanced Psychopharmacology for Psychiatrists. Academic Psychiatry 43:4, pages 411-416.
Crossref
Crossref
Thomas Vanicek, Georg S. Kranz, Benjamin Vyssoki, Gernot Fugger, Arkadiusz Komorowski, Anna Höflich, Gertraud Saumer, Sergej Milovic, Rupert Lanzenberger, Anne Eckert, Siegfried Kasper & Richard Frey. (2019) Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression. Brain Stimulation 12:4, pages 1041-1050.
Crossref
Crossref
K. L. Musliner, X. Liu, C. Gasse, K. S. Christensen, T. Wimberley & T. Munk‐Olsen. (2019) Incidence of medically treated depression in Denmark among individuals 15–44 years old: a comprehensive overview based on population registers. Acta Psychiatrica Scandinavica 139:6, pages 548-557.
Crossref
Crossref
Gregor Gryglewski, Manfred Klöbl, Neydher Berroterán-Infante, Lucas Rischka, Theresa Balber, Thomas Vanicek, Verena Pichler, Alexander Kautzky, Eva-Maria Klebermass, Murray Bruce Reed, Chrysoula Vraka, Marius Hienert, Gregory Miles James, Leo Silberbauer, Godber Mathis Godbersen, Jakob Unterholzner, Paul Michenthaler, Markus Hartenbach, Edda Winkler-Pjrek, Wolfgang Wadsak, Markus Mitterhauser, Andreas Hahn, Marcus Hacker, Siegfried Kasper & Rupert Lanzenberger. (2019) Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging. European Neuropsychopharmacology 29:6, pages 711-719.
Crossref
Crossref
Tatsuo Akechi, Akio Mantani, Ken'ichi Kurata, Susumu Hirota, Shinji Shimodera, Mitsuhiko Yamada, Masatoshi Inagaki, Norio Watanabe, Tadashi Kato & Toshi A. Furukawa. (2019) Predicting relapse in major depression after successful initial pharmacological treatment. Journal of Affective Disorders 250, pages 108-113.
Crossref
Crossref
Dietmar Winkler, Berthold Reichardt, Georg S. Kranz, Lucie Bartova, Siegfried Kasper & Edda Pjrek. (2019) Seasonality of antidepressant prescriptions and sick leaves. Journal of Psychiatric Research 111, pages 128-133.
Crossref
Crossref
Amber R. Thompson, Aekta Malhotra & Anthony J. Rothschild. (2019) Advances in the Treatment of Psychotic Depression. Current Treatment Options in Psychiatry 6:1, pages 64-74.
Crossref
Crossref
Suresh Durgam, Changzheng Chen, Raffaele Migliore, Chandran Prakash & Michael E. Thase. (2019) Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study. Depression and Anxiety 36:3, pages 225-234.
Crossref
Crossref
Amanda J. Sales, Manoela V. Fogaça, Ariandra G. Sartim, Vitor S. Pereira, Gregers Wegener, Francisco S. Guimarães & Sâmia R. L. Joca. (2018) Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Molecular Neurobiology 56:2, pages 1070-1081.
Crossref
Crossref
I. Grande. (2019) C.05.01 Traditional efficacy of antidepressants: Does it reflect your long-term treatment goals?. European Neuropsychopharmacology 29, pages S621-S622.
Crossref
Crossref
M. Bauer, S. Priebe & E. Severus. 2019. Traumafolgestörungen. Traumafolgestörungen
365
378
.
Nefize Yalin & Allan H. Young. 2019. Age of Onset of Mental Disorders. Age of Onset of Mental Disorders
111
124
.
Alexander Kautzky, Rupert Lanzenberger & Siegfried Kasper. 2019. Personalized Psychiatry. Personalized Psychiatry
53
76
.
Abebaw Fekadu, Jacek G. Donocik & Anthony J. Cleare. (2018) Standardisation framework for the Maudsley staging method for treatment resistance in depression. BMC Psychiatry 18:1.
Crossref
Crossref
Kwan Woo Choi, Eun Jin Na, Maurizio Fava, David Mischoulon, Hana Cho & Hong Jin Jeon. (2018) Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder. Psychiatry Research 270, pages 246-252.
Crossref
Crossref
Joachim Benitez, Christina L Cool & Dennis J Scotti. (2018) Use of combinatorial pharmacogenomic guidance in treating psychiatric disorders. Personalized Medicine 15:6, pages 481-494.
Crossref
Crossref
María Luisa González Moral, Carmen Selva Sevilla, Patricia Romero Rodenas, María Teresa Tolosa Pérez, Marta Lucas Pérez-Romero, Mar Domato Lluch & Manuel Gerónimo Pardo. (2018) Influence of propofol dose and blood components on duration of electrical seizures in electroconvulsive therapy. Brazilian Journal of Anesthesiology (English Edition) 68:6, pages 564-570.
Crossref
Crossref
María Luisa González Moral, Carmen Selva Sevilla, Patricia Romero Rodenas, María Teresa Tolosa Pérez, Marta Lucas Pérez‐Romero, Mar Domato Lluch & Manuel Gerónimo Pardo. (2018) Influência da dose de propofol e dos componentes sanguíneos na duração das convulsões elétricas em eletroconvulsoterapia. Brazilian Journal of Anesthesiology 68:6, pages 564-570.
Crossref
Crossref
Masahiro Banno, Yudai Harada, Masashi Taniguchi, Ryo Tobita, Hiraku Tsujimoto, Yasushi Tsujimoto, Yuki Kataoka & Akiko Noda. (2018) Exercise can improve sleep quality: a systematic review and meta-analysis. PeerJ 6, pages e5172.
Crossref
Crossref
Zhenghua Hou, Youyong Kong, Xiaofu He, Yingying Yin, Yuqun Zhang & Yonggui Yuan. (2018) Increased temporal variability of striatum region facilitating the early antidepressant response in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 85, pages 39-45.
Crossref
Crossref
A. J. Bayes & G. B. Parker. (2018) Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation. Acta Psychiatrica Scandinavica 137:6, pages 459-471.
Crossref
Crossref
Marlijn Vermeiden, Astrid M. Kamperman, Witte J.G. Hoogendijk, Walter W. van den Broek & Tom K. Birkenhäger. (2018) Outcome of a three-phase treatment algorithm for inpatients with melancholic depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, pages 214-220.
Crossref
Crossref
Baris Olten & Michael H. Bloch. (2018) Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, pages 272-281.
Crossref
Crossref
Shani Stern, Sara Linker, Krishna C. Vadodaria, Maria C. Marchetto & Fred H. Gage. (2018) Prediction of response to drug therapy in psychiatric disorders. Open Biology 8:5, pages 180031.
Crossref
Crossref
L. Grassi, M.G. Nanni, G. Rodin, M. Li & R. Caruso. (2018) The use of antidepressants in oncology: a review and practical tips for oncologists. Annals of Oncology 29:1, pages 101-111.
Crossref
Crossref
Tomáš Novák. (2017) Trends in pharmacotherapy of unipolar depression. Psychiatrie pro praxi 18:3, pages 120-124.
Crossref
Crossref
Mohammed T. Abou-Saleh, Bruno Müller-Oerlinghausen & Alec J. Coppen. (2017) Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression. International Journal of Bipolar Disorders 5:1.
Crossref
Crossref
Chad A. Bousman, Philip Jaksa & Christos Pantelis. (2017) Systematic evaluation of commercial pharmacogenetic testing in psychiatry. Pharmacogenetics and Genomics 27:11, pages 387-393.
Crossref
Crossref
Stefanie Wagner, Alice Engel, Jan Engelmann, David Herzog, Nadine Dreimüller, Marianne B. Müller, André Tadić & Klaus Lieb. (2017) Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis. Journal of Psychiatric Research 94, pages 96-106.
Crossref
Crossref
R. Haussmann, U. Lewitzka, E. Severus & M. Bauer. (2017) Sachgerechte Behandlung affektiver Störungen mit LithiumCorrect treatment of mood disorders with lithium. Der Nervenarzt 88:11, pages 1323-1334.
Crossref
Crossref
Daniel J. Safer. (2017) Differing antidepressant maintenance methodologies. Contemporary Clinical Trials 61, pages 87-95.
Crossref
Crossref
Mazda Adli, Katja Wiethoff, Thomas C Baghai, Robert Fisher, Florian Seemüller, Gregor Laakmann, Peter Brieger, Joachim Cordes, Jaroslav Malevani, Gerd Laux, Iris Hauth, Hans-Jürgen Möller, Klaus-Thomas Kronmüller, Michael N Smolka, Peter Schlattmann, Maximilian Berger, Roland Ricken, Thomas J Stamm, Andreas Heinz & Michael Bauer. (2017) How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial. International Journal of Neuropsychopharmacology 20:9, pages 721-730.
Crossref
Crossref
Eduard Vieta, Henrik Loft & Ioana Florea. (2017) Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder. European Neuropsychopharmacology 27:9, pages 877-884.
Crossref
Crossref
Hee Ryung Wang, Won-Myong Bahk, Jeong Seok Seo, Young Sup Woo, Young-Min Park, Jong-Hyun Jeong, Won Kim, Se-Hoon Shim, Jung Goo Lee, Duk-In Jon & Kyung Joon Min. (2017) Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 15:3, pages 199-209.
Crossref
Crossref
M. Vermeiden, A. M. Kamperman, W. J. G. Hoogendijk, W. W. van den Broek & T. K. Birkenhäger. (2017) A randomized clinical trial comparing two two‐phase treatment strategies for in‐patients with severe depression. Acta Psychiatrica Scandinavica 136:1, pages 118-128.
Crossref
Crossref
Kimberly Peterson, Eric Dieperink, Johanna Anderson, Erin Boundy, Lauren Ferguson & Mark Helfand. (2017) Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder. Psychopharmacology 234:11, pages 1649-1661.
Crossref
Crossref
Xuelian Cui, Wei Niu, Lingming Kong, Mingjun He, Kunhong Jiang, Shengdong Chen, Aifang Zhong, Wanshuai Li, Jim Lu & Liyi Zhang. (2017) Can lncRNAs be indicators for the diagnosis of early onset or acute schizophrenia and distinguish major depressive disorder and generalized anxiety disorder?-A cross validation analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174:4, pages 335-341.
Crossref
Crossref
Julia Kleeblatt, Felix Betzler, Laura L. Kilarski, Tom Bschor & Stephan Köhler. (2017) Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence. European Neuropsychopharmacology 27:5, pages 423-441.
Crossref
Crossref
Victor I Reus. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
8
.
Gin S Malhi, Amber Hamilton, Grace Morris, Pritha Das & Tim Outhred. (2017) Optimisation of adherence and discontinuation practices for maintenance antidepressant therapy. Australian & New Zealand Journal of Psychiatry 51:4, pages 403-405.
Crossref
Crossref
Frank M. Schmidt, Christian Sander, Marie-Elisa Dietz, Claudia Nowak, Thomas Schröder, Roland Mergl, Peter Schönknecht, Hubertus Himmerich & Ulrich Hegerl. (2017) Brain arousal regulation as response predictor for antidepressant therapy in major depression. Scientific Reports 7:1.
Crossref
Crossref
D. Yu. Veltishchev, O. B. Kovalevskaya & O. F. Seravina. (2017) Risk factors and prevention of recurrent dynamics of depression. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:6, pages 120.
Crossref
Crossref
Ulrich Hegerl & Dan Rujescu. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2875
2896
.
Markus Dold, Alexander Kautzky, Lucie Bartova, Ulrich Rabl, Daniel Souery, Julien Mendlewicz, Stefano Porcelli, Alessandro Serretti, Joseph Zohar, Stuart Montgomery & Siegfried Kasper. (2016) Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study. European Neuropsychopharmacology 26:12, pages 1960-1971.
Crossref
Crossref
Ali Ghaleiha, Hassan Davari, Leila Jahangard, Mohammad Haghighi, Mohammad Ahmadpanah, Mohammad Ali Seifrabie, Hafez Bajoghli, Edith Holsboer-Trachsler & Serge Brand. (2016) Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial. European Archives of Psychiatry and Clinical Neuroscience 266:8, pages 695-702.
Crossref
Crossref
Kang Sim, Wai Keat Lau, Jordan Sim, Min Yi Sum & Ross J. Baldessarini. (2016) Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials. International Journal of Neuropsychopharmacology 19:2, pages pyv076.
Crossref
Crossref
Dorte Lassen, Zandra Nymand Ennis & Per Damkier. (2016) First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review. Basic & Clinical Pharmacology & Toxicology 118:1, pages 32-36.
Crossref
Crossref
Ulrich Hegerl & Dan Rujescu. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
22
.
Michael Bauer & Michael GitlinMichael Bauer & Michael Gitlin. 2016. The Essential Guide to Lithium Treatment. The Essential Guide to Lithium Treatment
45
60
.
Alexandra Bernegger, Klemens Kienesberger, Laura Carlberg, Patrick Swoboda, Birgit Ludwig, Romina Koller, Nestor D. Kapusta, Martin Aigner, Helmuth Haslacher, Michaela Schmöger, Siegfried Kasper & Alexandra Schosser. (2015) Influence of Sex on Suicidal Phenotypes in Affective Disorder Patients with Traumatic Childhood Experiences. PLOS ONE 10:9, pages e0137763.
Crossref
Crossref